{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:07:00Z","timestamp":1785002820977,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T00:00:00Z","timestamp":1341878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00228-012-1345-z","type":"journal-article","created":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T20:26:22Z","timestamp":1341865582000},"page":"341-346","source":"Crossref","is-referenced-by-count":24,"title":["Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia"],"prefix":"10.1007","volume":"69","author":[{"given":"Liliana","family":"Grigore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Raselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Garlaschelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Redaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe D.","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico L.","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,10]]},"reference":[{"issue":"2","key":"1345_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.CIR.79.2.287","volume":"79","author":"SW Werns","year":"1989","unstructured":"Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B (1989) Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 79(2):287\u2013291","journal-title":"Circulation"},{"issue":"8","key":"1345_CR2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15(8):1983\u20131992","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"1345_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","volume":"320","author":"D Steinberg","year":"1989","unstructured":"Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320(14):915\u2013924","journal-title":"N Engl J Med"},{"issue":"1","key":"1345_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3121\/cmr.4.1.53","volume":"4","author":"Z Yang","year":"2006","unstructured":"Yang Z, Ming XF (2006) Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 4(1):53\u201365","journal-title":"Clin Med Res"},{"key":"1345_CR5","unstructured":"Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4\u00a0S). Lancet 344 (8934): 1383-1389"},{"issue":"20","key":"1345_CR6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333(20):1301\u20131307","journal-title":"N Engl J Med"},{"issue":"1","key":"1345_CR7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","volume":"95","author":"O Tamai","year":"1997","unstructured":"Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T (1997) Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95(1):76\u201382","journal-title":"Circulation"},{"issue":"8","key":"1345_CR8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","volume":"332","author":"TJ Anderson","year":"1995","unstructured":"Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332(8):488\u2013493","journal-title":"N Engl J Med"},{"issue":"7","key":"1345_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","volume":"83","author":"M Essig","year":"1998","unstructured":"Essig M, Nguyen G, Prie D, Escoubet B, Sraer JD, Friedlander G (1998) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 83(7):683\u2013690","journal-title":"Circ Res"},{"issue":"50","key":"1345_CR10","doi-asserted-by":"crossref","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","volume":"272","author":"U Laufs","year":"1997","unstructured":"Laufs U, Fata VL, Liao JK (1997) Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272(50):31725\u201331729","journal-title":"J Biol Chem"},{"issue":"5","key":"1345_CR11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","volume":"95","author":"G O'Driscoll","year":"1997","unstructured":"O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1\u00a0month. Circulation 95(5):1126\u20131131","journal-title":"Circulation"},{"issue":"1","key":"1345_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.ATV.21.1.3","volume":"21","author":"W Palinski","year":"2001","unstructured":"Palinski W (2001) New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol 21(1):3\u20135","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1345_CR13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","volume":"22","author":"S Wassmann","year":"2002","unstructured":"Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22(2):300\u2013305","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1345_CR14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","volume":"90","author":"C Gagne","year":"2002","unstructured":"Gagne C, Bays HE, Weiss SR, Mata P, Quinto K, Melino M, Cho M, Musliner TA, Gumbiner B (2002) Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 90(10):1084\u20131091","journal-title":"Am J Cardiol"},{"issue":"6","key":"1345_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00132580-200211000-00011","volume":"4","author":"EK Gupta","year":"2002","unstructured":"Gupta EK, Ito MK (2002) Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors. Heart Dis 4(6):399\u2013409","journal-title":"Heart Dis"},{"issue":"4","key":"1345_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000088105","volume":"104","author":"D Bulut","year":"2005","unstructured":"Bulut D, Hanefeld C, Bulut-Streich N, Graf C, Mugge A, Spiecker M (2005) Endothelial function in the forearm circulation of patients with the metabolic syndrome\u2013effect of different lipid-lowering regimens. Cardiology 104(4):176\u2013180","journal-title":"Cardiology"},{"issue":"14","key":"1345_CR17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehn166","volume":"29","author":"M Settergren","year":"2008","unstructured":"Settergren M, Bohm F, Ryden L, Pernow J (2008) Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 29(14):1753\u20131760","journal-title":"Eur Heart J"},{"issue":"9","key":"1345_CR18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","volume":"50","author":"KM Maki-Petaja","year":"2007","unstructured":"Maki-Petaja KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB (2007) Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 50(9):852\u2013858","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1345_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/FJC.0b013e31817ffe76","volume":"52","author":"JK Olijhoek","year":"2008","unstructured":"Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL (2008) The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial. J Cardiovasc Pharmacol 52(2):145\u2013150","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18","key":"1345_CR20","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1161\/01.CIR.0000164260.82417.3F","volume":"111","author":"U Landmesser","year":"2005","unstructured":"Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de Groot K, Fliser D, Fauler G, Marz W, Drexler H (2005) Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 111(18):2356\u20132363","journal-title":"Circulation"},{"issue":"1","key":"1345_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2008.12.067","volume":"142","author":"P Gounari","year":"2010","unstructured":"Gounari P, Tousoulis D, Antoniades C, Kampoli AM, Stougiannos P, Papageorgiou N, Roulia G, Stefanadi E, Siasos G, Tsioufis C, Stefanadis C (2010) Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering. Int J Cardiol 142(1):87\u201391","journal-title":"Int J Cardiol"},{"issue":"1","key":"1345_CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","volume":"119","author":"PY Liu","year":"2009","unstructured":"Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK (2009) Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 119(1):131\u2013138","journal-title":"Circulation"},{"issue":"2","key":"1345_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00228-006-0238-4","volume":"63","author":"S Efrati","year":"2007","unstructured":"Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A (2007) The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers. Eur J Clin Pharmacol 63(2):113\u2013121","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"1345_CR24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurheartj\/ehi881","volume":"27","author":"S Fichtlscherer","year":"2006","unstructured":"Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rossig L, Heeschen C, Dimmeler S, Zeiher AM (2006) Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. Eur Heart J 27(10):1182\u20131190","journal-title":"Eur Heart J"},{"issue":"1","key":"1345_CR25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2008.11.032","volume":"205","author":"MA Ostad","year":"2009","unstructured":"Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Boger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A (2009) Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis 205(1):227\u2013232","journal-title":"Atherosclerosis"},{"issue":"4","key":"1345_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.77.4.297","volume":"77","author":"MJ Mullen","year":"1997","unstructured":"Mullen MJ, Thorne SA, Deanfield JE, Jones CJ (1997) Non-invasive assessment of endothelial function. Heart 77(4):297\u2013298","journal-title":"Heart"},{"issue":"6","key":"1345_CR27","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2003-031977","volume":"89","author":"FM Maggi","year":"2004","unstructured":"Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappie S, Catapano AL (2004) Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab 89(6):2946\u20132950","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1345_CR28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.atherosclerosis.2009.03.017","volume":"206","author":"GD Norata","year":"2009","unstructured":"Norata GD, Raselli S, Grigore L, Garlaschelli K, Vianello D, Bertocco S, Zambon A, Catapano AL (2009) Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 206(2):556\u2013562","journal-title":"Atherosclerosis"},{"issue":"4","key":"1345_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1538574410362922","volume":"44","author":"B Sadowitz","year":"2010","unstructured":"Sadowitz B, Maier KG, Gahtan V (2010) Basic science review: Statin therapy\u2013Part I: The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 44(4):241\u2013251","journal-title":"Vasc Endovascular Surg"},{"issue":"12","key":"1345_CR30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97(12):1129\u20131135","journal-title":"Circulation"},{"issue":"3","key":"1345_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI200113152","volume":"108","author":"S Dimmeler","year":"2001","unstructured":"Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway. J Clin Invest 108(3):391\u2013397","journal-title":"J Clin Invest"},{"issue":"9","key":"1345_CR32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.RES.0000070067.64040.7C","volume":"92","author":"B Assmus","year":"2003","unstructured":"Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, Spyridopoulos I, Zeiher AM, Dimmeler S (2003) HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92(9):1049\u20131055","journal-title":"Circ Res"},{"issue":"3","key":"1345_CR33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI200113131","volume":"108","author":"J Llevadot","year":"2001","unstructured":"Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T (2001) HMG-CoA reductase inhibitor mobilizes bone marrow\u2013derived endothelial progenitor cells. J Clin Invest 108(3):399\u2013405","journal-title":"J Clin Invest"},{"issue":"13","key":"1345_CR34","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(88)90236-5","volume":"37","author":"S Moncada","year":"1988","unstructured":"Moncada S, Radomski MW, Palmer RM (1988) Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37(13):2495\u20132501","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1345_CR35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1172\/JCI114688","volume":"86","author":"MA Creager","year":"1990","unstructured":"Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86(1):228\u2013234","journal-title":"J Clin Invest"},{"issue":"6","key":"1345_CR36","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/01.CIR.88.6.2541","volume":"88","author":"PR Casino","year":"1993","unstructured":"Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA (1993) The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88(6):2541\u20132547","journal-title":"Circulation"},{"issue":"2","key":"1345_CR37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23(2):168\u2013175","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1345_CR38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(99)00189-6","volume":"147","author":"MJ Jarvisalo","year":"1999","unstructured":"Jarvisalo MJ, Toikka JO, Vasankari T, Mikkola J, Viikari JS, Hartiala JJ, Raitakari OT (1999) HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis 147(2):237\u2013242","journal-title":"Atherosclerosis"},{"issue":"4","key":"1345_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10557-007-6038-y","volume":"21","author":"T Inoue","year":"2007","unstructured":"Inoue T, Node K (2007) Statin therapy for vascular failure. Cardiovasc Drugs Ther 21(4):281\u2013295","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"1345_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","volume":"20","author":"AH Wagner","year":"2000","unstructured":"Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M (2000) Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20(1):61\u201369","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1345_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","volume":"103","author":"O Feron","year":"2001","unstructured":"Feron O, Dessy C, Desager JP, Balligand JL (2001) Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103(1):113\u2013118","journal-title":"Circulation"},{"issue":"6","key":"1345_CR42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/clc.4960250610","volume":"25","author":"M Frick","year":"2002","unstructured":"Frick M, Alber HF, Hugel H, Schwarzacher SP, Pachinger O, Weidinger F (2002) Short- and long-term changes of flow-mediated vasodilation in patients under statin therapy. Clin Cardiol 25(6):291\u2013294","journal-title":"Clin Cardiol"},{"issue":"25","key":"1345_CR43","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","volume":"99","author":"J Dupuis","year":"1999","unstructured":"Dupuis J, Tardif JC, Cernacek P, Theroux P (1999) Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 99(25):3227\u20133233","journal-title":"Circulation"},{"issue":"6","key":"1345_CR44","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.89.6.2519","volume":"89","author":"K Egashira","year":"1994","unstructured":"Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89(6):2519\u20132524","journal-title":"Circulation"},{"issue":"6119","key":"1345_CR45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/327237a0","volume":"327","author":"HE Andrews","year":"1987","unstructured":"Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M (1987) Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 327(6119):237\u2013239","journal-title":"Nature"},{"issue":"1","key":"1345_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jca.20000","volume":"19","author":"K Igarashi","year":"2004","unstructured":"Igarashi K, Tsuji M, Nishimura M, Horimoto M (2004) Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia. J Clin Apher 19(1):11\u201316","journal-title":"J Clin Apher"},{"issue":"8","key":"1345_CR47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","volume":"332","author":"CB Treasure","year":"1995","unstructured":"Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332(8):481\u2013487","journal-title":"N Engl J Med"},{"issue":"4","key":"1345_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2125.2002.01677.x","volume":"54","author":"H Omori","year":"2002","unstructured":"Omori H, Nagashima H, Tsurumi Y, Takagi A, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H (2002) Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol 54(4):395\u2013399","journal-title":"Br J Clin Pharmacol"},{"issue":"23 Suppl 1","key":"1345_CR49","first-page":"III39","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J (2004) Beneficial cardiovascular pleiotropic effects of statins. Circulation 109[23 Suppl 1]:III39\u2013III43","journal-title":"Circulation"},{"issue":"21 Suppl 1","key":"1345_CR50","first-page":"II18","volume":"109","author":"U Schonbeck","year":"2004","unstructured":"Schonbeck U, Libby P (2004) Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109[21 Suppl 1]:II18\u2013II26","journal-title":"Circulation"},{"issue":"2","key":"1345_CR51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","volume":"198","author":"GR Thompson","year":"2008","unstructured":"Thompson GR (2008) Recommendations for the use of LDL apheresis. Atherosclerosis 198(2):247\u2013255","journal-title":"Atherosclerosis"},{"issue":"6","key":"1345_CR52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","volume":"21","author":"GR Thompson","year":"2010","unstructured":"Thompson GR, Catapano A, Saheb S, Atassi-Dumont M, Barbir M, Eriksson M, Paulweber B, Sijbrands E, Stalenhoef AF, Parhofer KG (2010) Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe. Curr Opin Lipidol 21(6):492\u2013498","journal-title":"Curr Opin Lipidol"},{"issue":"9784","key":"1345_CR53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377(9784):2181\u20132192","journal-title":"Lancet"},{"issue":"3","key":"1345_CR54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","volume":"10","author":"TT Abd","year":"2011","unstructured":"Abd TT, Jacobson TA (2011) Statin-induced myopathy: a review and update. Expert Opin Drug Saf 10(3):373\u2013387","journal-title":"Expert Opin Drug Saf"},{"issue":"9601","key":"1345_CR55","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage J (2007) The safety of statins in clinical practice. Lancet 370(9601):1781\u20131790","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1345-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1345-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1345-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:48:59Z","timestamp":1558687739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1345-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,10]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1345-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,10]]}}}